With a $10 billion settlement looming, Purdue Pharma, the manufacturer of OxyContin, filed for Chapter 11 bankruptcy this week. OxyContin, which courts are holding responsible as the catalyst for the nation’s opioid crisis, currently holds preferred formulary status for 29% of all covered lives.

SOURCE: MMIT Analytics, as of 9/17/19